Epidarex Exeed Limited
Epidarex Exeed Limited
#SC639047 • Active
B2b
Epidarex Exeed specializes in seeding early-stage and highly innovative life sciences assets to create companies based on breakthrough science, applying strong drug discovery and project management capabilities to transform innovations into investable assets.
Founded: 16/08/2019
Industries: Research and experimental development on biotechnology
Website: https://epidarex-exeed.com
Email: Subscribe to view
Location: Edinburgh, United Kingdom
Financial Snapshot
Last accounts made up to 31 March 2024
Next accounts due 31 December 2025 (7 months)
Cash in Bank £1.01m
↑ 54%
Total Liabilities £214,089
↓ -58%
Employees 2
↑ 0%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Peter Michael Finan | Company Director | 26/09/2019 | British | 57 years |
| Henning Klaus-willi Christian Steinhagen | Director | 16/08/2019 | German | 55 years |
| Elizabeth Ann Roper | Partner Epidarex | 16/08/2019 | Irish | 50 years |
Role:
Company Director
Appointed:
26/09/2019
Nationality:
British
Age:
57 years
Role:
Director
Appointed:
16/08/2019
Nationality:
German
Age:
55 years
Role:
Partner Epidarex
Appointed:
16/08/2019
Nationality:
Irish
Age:
50 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Epidarex Capital Iii Uk, Lp | Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors | 16/08/2019 | United Kingdom |
Nature of Control:
Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors
Notified On:
16/08/2019
Nationality:
United Kingdom
Financial Accounts
| Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
No charges registered
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 30/12/2024 | Accounts | Accounts With Accounts Type Small | View (10 pages) |
| 11/09/2024 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 20/12/2023 | Accounts | Accounts With Accounts Type Small | View (11 pages) |
| 04/10/2023 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 30/01/2023 | Accounts | Accounts With Accounts Type Small | View (12 pages) |
| 23/11/2022 | Gazette | Gazette Filings Brought Up To Date | View (1 page) |
| 22/11/2022 | Gazette | Gazette Notice Compulsory | View (1 page) |